Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

LYVE-1 upregulation and lymphatic invasion correlate with adverse prognostic factors and lymph node metastasis in neuroblastoma.

Ramani P, Dungwa JV, May MT.

Virchows Arch. 2012 Feb;460(2):183-91. doi: 10.1007/s00428-011-1190-y.

PMID:
22241180
2.

PROX1 lymphatic density correlates with adverse clinicopathological factors, lymph node metastases and survival in neuroblastomas.

Ramani P, Norton A, Somerville MS, May MT.

J Neurooncol. 2012 Jul;108(3):375-83. doi: 10.1007/s11060-012-0838-z.

PMID:
22382784
3.

Podoplanin lymphatic density and invasion correlate with adverse clinicopathologic and biological factors and survival in neuroblastomas.

Ramani P, Somerville MS, May MT.

Am J Surg Pathol. 2012 Jun;36(6):908-15. doi: 10.1097/PAS.0b013e31824c0db9.

PMID:
22588067
4.

Role of urokinase plasminogen activator and its receptor in metastasis and invasion of neuroblastoma.

Li P, Gao Y, Ji Z, Zhang X, Xu Q, Li G, Guo Z, Zheng B, Guo X.

J Pediatr Surg. 2004 Oct;39(10):1512-9.

PMID:
15486896
5.

VEGF-C, VEGF-D and VEGFR-3 expression in peripheral neuroblastic tumours.

Ramani P, Nash R, Radevsky L, Patel A, Luckett M, Rogers C.

Histopathology. 2012 Dec;61(6):1006-16. doi: 10.1111/j.1365-2559.2012.04307.x.

PMID:
22804730
6.

HIF-1α up-regulation is associated with adverse clinicopathological and biological factors in neuroblastomas.

Dungwa JV, Hunt LP, Ramani P.

Histopathology. 2012 Sep;61(3):417-27. doi: 10.1111/j.1365-2559.2012.04227.x.

PMID:
22571395
7.

Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group.

Goto S, Umehara S, Gerbing RB, Stram DO, Brodeur GM, Seeger RC, Lukens JN, Matthay KK, Shimada H.

Cancer. 2001 Nov 15;92(10):2699-708.

PMID:
11745206
8.

Intraocular tumor-associated lymphangiogenesis a novel prognostic factor for ciliary body melanomas with extraocular extension?

Heindl LM, Hofmann TN, Adler W, Knorr HL, Holbach LM, Naumann GO, Kruse FE, Cursiefen C.

Ophthalmology. 2010 Feb;117(2):334-42. doi: 10.1016/j.ophtha.2009.06.057.

PMID:
19892405
9.

Intratumoral lymphatics and lymphatic vessel invasion detected by D2-40 are essential for lymph node metastasis in bladder transitional cell carcinoma.

Ma Y, Hou Y, Liu B, Li X, Yang S, Ma J.

Anat Rec (Hoboken). 2010 Nov;293(11):1847-54. doi: 10.1002/ar.21217.

10.

Detection of lymphangiogenesis in non-small cell lung cancer and its prognostic value.

Sun JG, Wang Y, Chen ZT, Zhuo WL, Zhu B, Liao RX, Zhang SX.

J Exp Clin Cancer Res. 2009 Feb 16;28:21. doi: 10.1186/1756-9966-28-21.

11.

[Expression of LYVE-1 and Prox-1 in non-small cell lung cancer and the relationship with lymph node metastasis].

Chang C, Wang P, Yang H, Li L, Zhang LB.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2011 Mar;42(2):174-8. Chinese.

PMID:
21500548
13.

Lymphatic microvessel density is an independent prognostic factor in colorectal cancer.

Matsumoto K, Nakayama Y, Inoue Y, Minagawa N, Katsuki T, Shibao K, Tsurudome Y, Hirata K, Nagata N, Itoh H.

Dis Colon Rectum. 2007 Mar;50(3):308-14.

PMID:
17164964
14.

Significance of lymphatic invasion on regional lymph node metastasis in early gastric cancer using LYVE-1 immunohistochemical analysis.

Fujimoto A, Ishikawa Y, Akishima-Fukasawa Y, Ito K, Akasaka Y, Tamai S, Maehara T, Kiguchi H, Ogata K, Nishimura C, Miki K, Ishii T.

Am J Clin Pathol. 2007 Jan;127(1):82-8.

PMID:
17145628
15.

Prognostic significance of HER2 expression in neuroblastic tumors.

Izycka-Swieszewska E, Wozniak A, Kot J, Grajkowska W, Balcerska A, Perek D, Dembowska-Baginska B, Klepacka T, Drozynska E.

Mod Pathol. 2010 Sep;23(9):1261-8. doi: 10.1038/modpathol.2010.115.

16.

D2-40/p63 defined lymph vessel invasion has additional prognostic value in highly proliferating operable node negative breast cancer patients.

Gudlaugsson E, Skaland I, Undersrud E, Janssen EA, Søiland H, Baak JP.

Mod Pathol. 2011 Apr;24(4):502-11. doi: 10.1038/modpathol.2010.199.

17.

Prognostic value of lymphangiogenesis in supraglottic laryngeal carcinoma.

Lin JY, Li XY, Dong P, Nakashima T.

J Laryngol Otol. 2011 Sep;125(9):945-51. doi: 10.1017/S0022215111001514.

PMID:
21774849
18.

Aurora kinase A is superior to Ki67 as a prognostic indicator of survival in neuroblastoma.

Ramani P, Nash R, Rogers CA.

Histopathology. 2015 Feb;66(3):370-9. doi: 10.1111/his.12520.

PMID:
25297850
19.

Tumour expression of lymphangiogenic growth factors but not lymphatic vessel density is implicated in human cervical cancer progression.

Sotiropoulou N, Bravou V, Kounelis S, Damaskou V, Papaspirou E, Papadaki H.

Pathology. 2010 Dec;42(7):629-36. doi: 10.3109/00313025.2010.522174.

PMID:
21080871
20.

Quantitative analysis of lymphangiogenic markers in human gastroenteric tumor.

Yuanming L, Feng G, Lei T, Ying W.

Arch Med Res. 2007 Jan;38(1):106-12.

PMID:
17174733
Items per page

Supplemental Content

Support Center